{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:53:24Z","timestamp":1791647604072,"version":"4.3.4"},"reference-count":203,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018607","name":"Henan Province Science and Technology Innovation Talent Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273927"],"award-info":[{"award-number":["82273927"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.arr.2026.103336","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:17:27Z","timestamp":1787588247000},"page":"103336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanisms and therapeutic strategies for VEGFR inhibitor-induced cardiotoxicity and hepatotoxicity in cancer therapy"],"prefix":"10.1016","volume":"122","author":[{"given":"Yajie","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiubin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zining","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2026.103336_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173229","article-title":"The protective effect of losartan against sorafenib induced cardiotoxicity: Ex-vivo isolated heart and metabolites profiling studies in rat","volume":"882","author":"Abdelgalil","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41569-023-00881-3","article-title":"Hallmarks of cardiovascular ageing","volume":"20","author":"Abdellatif","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.arr.2026.103336_bib3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.31083\/ph.2021.1684","article-title":"Tacrolimus and herbs interactions: a review","volume":"76","author":"Abushammala","year":"2021","journal-title":"Pharmazie"},{"key":"10.1016\/j.arr.2026.103336_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jhep.2016.03.012","article-title":"A fatty liver leads to a broken heart?","volume":"65","author":"Adams","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.arr.2026.103336_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11912-018-0708-8","article-title":"Tyrosine kinase inhibitor-induced hypertension","volume":"20","author":"Agarwal","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.arr.2026.103336_bib6","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2217\/imt-2022-0013","article-title":"Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinib","volume":"14","author":"Air\u00f2","year":"2022","journal-title":"Immunotherapy"},{"key":"10.1016\/j.arr.2026.103336_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7453406","article-title":"Elucidation of the molecular mechanisms underlying sorafenib-induced hepatotoxicity","volume":"2020","author":"AlAsmari","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.arr.2026.103336_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1229960","article-title":"Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)","volume":"14","author":"Altrocchi","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib9","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41598-023-28688-9","article-title":"Association between pazopanib exposure and safety in Japanese patients with renal cell carcinoma or soft tissue sarcoma","volume":"13","author":"Aoyama","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2026.103336_bib10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/cpr.12296","article-title":"Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR\/VEGFR-2-mediated pathway in breast cancer","volume":"49","author":"Balakrishnan","year":"2016","journal-title":"Cell. Prolif."},{"key":"10.1016\/j.arr.2026.103336_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10741-018-9716-x","article-title":"Role of cytokines and inflammation in heart function during health and disease","volume":"23","author":"Bartekova","year":"2018","journal-title":"Heart Fail. Rev."},{"issue":"11","key":"10.1016\/j.arr.2026.103336_bib12","doi-asserted-by":"crossref","first-page":"2500276","DOI":"10.1200\/GO-25-00276","article-title":"Geriatric Assessment: ASCO Global Guideline","author":"Bergerot","year":"2025","journal-title":"JCO Glob. Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.toxlet.2015.11.007","article-title":"Inflammatory and fibrotic processes are involved in the cardiotoxic effect of sunitinib: Protective role of L-carnitine","volume":"241","author":"Blanca","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.arr.2026.103336_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.toxlet.2020.11.003","article-title":"Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity","volume":"336","author":"Boran","year":"2021","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.arr.2026.103336_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2019.152281","article-title":"Mitochondrial oxidative stress plays a critical role in the cardiotoxicity of sunitinib: Running title: Sunitinib and oxidative stress in hearts","volume":"426","author":"Bouitbir","year":"2019","journal-title":"Toxicology"},{"key":"10.1016\/j.arr.2026.103336_bib16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3390\/metabo11090644","article-title":"An Extensive Metabolomics Workflow to Discover Cardiotoxin-Induced Molecular Perturbations in Microtissues","volume":"11","author":"Bowen","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.arr.2026.103336_bib17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1517\/14740338.2014.888413","article-title":"Axitinib safety in metastatic renal cell carcinoma: suggestions for daily clinical practice based on case studies","volume":"13","author":"Bracarda","year":"2014","journal-title":"Expert. Opin. Drug. Saf."},{"key":"10.1016\/j.arr.2026.103336_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000003721","article-title":"En-bloc simultaneous heart-liver transplantation in adult patients","volume":"274","author":"Brozzi","year":"2021","journal-title":"Ann. Surg."},{"key":"10.1016\/j.arr.2026.103336_bib19","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S1470-2045(15)00198-9","article-title":"Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"16","author":"Bruix","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/annonc\/mds431","article-title":"Safety and activity of sunitinib in elderly patients (\u2265 70 years) with metastatic renal cell carcinoma: a multicenter study","volume":"24","author":"Brunello","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib21","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00726-013-1662-2","article-title":"Glycine inhibits angiogenic signaling in human hepatocellular carcinoma cells","volume":"46","author":"Bruns","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.arr.2026.103336_bib22","doi-asserted-by":"crossref","DOI":"10.1007\/s11239-025-03151-w","article-title":"Tyrosine kinase inhibitors - balancing the haemostatic scales: a review of associated thrombosis and bleeding","author":"Butel-Simoes","year":"2025","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.arr.2026.103336_bib23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/HYPERTENSIONAHA.122.17947","article-title":"Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension-Mechanisms and Mitigation","volume":"80","author":"Butel-Simoes","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.arr.2026.103336_bib24","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCRESAHA.125.325492","article-title":"Decoding the liver-heart axis in cardiometabolic diseases","volume":"136","author":"Capone","year":"2025","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103336_bib25","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/liv.14941","article-title":"Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The CARDIO-SOR study","volume":"41","author":"Carballo-Folgoso","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.arr.2026.103336_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1152\/physiolgenomics.00041.2017","article-title":"Nrf2 at the heart of oxidative stress and cardiac protection","volume":"50","author":"Chen","year":"2018","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.arr.2026.103336_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/toxics11040309","article-title":"Aflatoxin-B1-Exposure-Induced Hepatic Injury Could Be Alleviated by Polydatin through Reducing Oxidative Stress, Inhibiting Inflammation and Improving Mitophagy","volume":"11","author":"Cheng","year":"2023","journal-title":"Toxics"},{"key":"10.1016\/j.arr.2026.103336_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2020.06.030","article-title":"Metformin: (future) best friend of the radiation oncologist?","volume":"151","author":"Chevalier","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ijms23010441","article-title":"Cancer therapy-induced cardiotoxicity-a metabolic perspective on pathogenesis, diagnosis and therapy","volume":"23","author":"Choksey","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103336_bib30","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1158\/1940-6207.CAPR-09-0155","article-title":"Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study","volume":"3","author":"Chow","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.arr.2026.103336_bib31","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0140-6736(07)61865-0","article-title":"Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib","volume":"370","author":"Chu","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2026.103336_bib32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/annonc\/mdw004","article-title":"A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma","volume":"27","author":"Ciuleanu","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1161\/HYP.0000000000000224","article-title":"Cancer therapy-related hypertension: A scientific statement from the american heart association","volume":"80","author":"Cohen","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.arr.2026.103336_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tox.2017.12.005","article-title":"Involvement of mitogen activated kinase kinase 7 intracellular signalling pathway in Sunitinib-induced cardiotoxicity","volume":"394","author":"Cooper","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.arr.2026.103336_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejim.2017.10.016","article-title":"Liver disease and heart failure: back and forth","volume":"48","author":"Correale","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.arr.2026.103336_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.toxlet.2022.06.001","article-title":"Downregulation of hERG channel expression by tyrosine kinase inhibitors nilotinib and vandetanib predominantly contributes to arrhythmogenesis","volume":"365","author":"Cui","year":"2022","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.arr.2026.103336_bib37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s11658-024-00655-w","article-title":"Early and late phases of liver sinusoidal endothelial cell (LSEC) defenestration in mouse model of systemic inflammation","volume":"29","author":"Czyzynska-Cichon","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.arr.2026.103336_bib38","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.23.00933","article-title":"Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update","volume":"41","author":"Dale","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103186","article-title":"Bleeding with vascular endothelial growth factor tyrosine kinase inhibitor: A network meta-analysis","volume":"157","author":"Das","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.arr.2026.103336_bib40","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.arr.2026.103336_bib41","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/pharmaceutics12090846","article-title":"Mechanisms of CYP450 inhibition: understanding drug-drug interactions due to mechanism-aased inhibition in clinical practice","volume":"12","author":"Deodhar","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2026.103336_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/15347354221078888","article-title":"Combination of shuangdan capsule and sorafenib inhibits tumor growth and angiogenesis in hepatocellular carcinoma via PI3K\/Akt\/mTORC1 pathway","volume":"21","author":"Ding","year":"2022","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.arr.2026.103336_bib43","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1152\/ajpgi.00575.2005","article-title":"Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity","volume":"291","author":"Donahower","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.arr.2026.103336_bib44","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.arr.2026.103336_bib45","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1161\/CIRCRESAHA.114.303200","article-title":"Sorafenib cardiotoxicity increases mortality after myocardial infarction","volume":"114","author":"Duran","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103336_bib46","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s10637-013-9962-7","article-title":"Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II study","volume":"31","author":"Eisen","year":"2013","journal-title":"Invest. New. Drugs"},{"key":"10.1016\/j.arr.2026.103336_bib47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/cells9030567","article-title":"Relationship between heart disease and liver disease: a two-way street","volume":"9","author":"El Hadi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.arr.2026.103336_bib48","first-page":"4057","article-title":"Meta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents","volume":"24","author":"Escalante","year":"2016","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.arr.2026.103336_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11523-020-00784-0","article-title":"Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib","volume":"16","author":"Fazio","year":"2021","journal-title":"Target. Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib50","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11427-017-9197-5","article-title":"AMPK and cardiac remodelling","volume":"61","author":"Feng","year":"2018","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.arr.2026.103336_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ygyno.2010.05.033","article-title":"A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer","volume":"119","author":"Friedlander","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib52","first-page":"478","article-title":"View on metformin: antidiabetic and pleiotropic effects, pharmacokinetics, side effects, and sex-related differences","volume":"17","author":"Froldi","year":"2024","journal-title":"Pharm. (Basel)"},{"issue":"1","key":"10.1016\/j.arr.2026.103336_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/1476-5926-10-8","article-title":"Evaluation of the effects of a VEGFR-2 inhibitor compound on alanine aminotransferase gene expression and enzymatic activity in the rat liver","volume":"10","author":"Fuentealba","year":"2011","journal-title":"Comp. Hepatol."},{"key":"10.1016\/j.arr.2026.103336_bib54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10549-013-2668-x","article-title":"Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling","volume":"141","author":"Fumarola","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.arr.2026.103336_bib55","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14740338.2019.1613371","article-title":"An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting TKI-based therapy","volume":"18","author":"Galvano","year":"2019","journal-title":"Expert. Opin. Drug. Saf."},{"key":"10.1016\/j.arr.2026.103336_bib56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.critrevonc.2014.11.006","article-title":"Hepatotoxicity with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis of randomized clinical trials","volume":"93","author":"Ghatalia","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.arr.2026.103336_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8479","article-title":"Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span","volume":"373","author":"Grunewald","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.arr.2026.103336_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115577","article-title":"Mitochondrial dynamics imbalance and mitochondrial dysfunction contribute to the molecular cardiotoxic effects of lenvatinib","volume":"423","author":"Gunaydin Akyildiz","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib59","article-title":"Crizotinib and sunitinib induce hepatotoxicity and mitochondrial apoptosis in L02 cells via ROS and Nrf2 signaling pathway","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib60","article-title":"An insight on the pathways involved in crizotinib and sunitinib induced hepatotoxicity in HepG2 cells and animal model","volume":"12","author":"Guo","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib61","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/jamainternmed.2020.9285","article-title":"Effect of a multifaceted clinical pharmacist intervention on medication safety after hospitalization in persons prescribed high-risk medications: a randomized clinical trial","volume":"181","author":"Gurwitz","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.arr.2026.103336_bib62","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/ehjci\/jead101","article-title":"Right ventricular myocarditis and rapid fibrosis induced by pazopanib","volume":"24","author":"Gwak","year":"2023","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.arr.2026.103336_bib63","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41388-022-02197-x","article-title":"PBLD inhibits angiogenesis via impeding VEGF\/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells","volume":"41","author":"Han","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.arr.2026.103336_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2024.101835","article-title":"Cancer therapy-associated cardiotoxicity: A look at frailty","volume":"15","author":"Hanlon","year":"2024","journal-title":"J. Geriatr. Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib65","first-page":"1","article-title":"Cardioprotection during chemotherapy: a case study to understand intracellular mechanisms to combat the cardiotoxicity of sunitinib","volume":"2013","author":"Hardip Sandhu","year":"2014","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.arr.2026.103336_bib66","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/cvr\/cvv152","article-title":"Oestrogen enhances cardiotoxicity induced by Sunitinib by regulation of drug transport and metabolism","volume":"107","author":"Harvey","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.arr.2026.103336_bib67","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.vascn.2013.04.009","article-title":"Effects of tyrosine kinase inhibitors on rat isolated heart function and protein biomarkers indicative of toxicity","volume":"68","author":"Henderson","year":"2013","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.arr.2026.103336_bib68","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/03602532.2017.1316285","article-title":"The importance of drug metabolites synthesis: the case-study of cardiotoxic anticancer drugs","volume":"49","author":"Hrynchak","year":"2017","journal-title":"Drug. Metab. Rev."},{"key":"10.1016\/j.arr.2026.103336_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152951","article-title":"Lenvatinib exposure induces hepatotoxicity in zebrafish via inhibiting Wnt signaling","volume":"462","author":"Huang","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.arr.2026.103336_bib70","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/bjc.2013.832","article-title":"Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma","volume":"110","author":"Hutson","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.arr.2026.103336_bib71","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/bcp.13895","article-title":"Cabozantinib-related cardiotoxicity: a prospective analysis in a real-world cohort of metastatic renal cell carcinoma patients","volume":"85","author":"Iacovelli","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib72","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/bcp.12231","article-title":"Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy","volume":"77","author":"Iacovelli","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib73","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00535-016-1263-4","article-title":"Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma","volume":"52","author":"Ikeda","year":"2017","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.arr.2026.103336_bib74","first-page":"217","article-title":"Acute heart failure following the initiation of cabozantinib, a multikinase inhibitor: A case report","volume":"26","author":"Ishiguchi","year":"2022","journal-title":"J. Cardiol. Cases"},{"key":"10.1016\/j.arr.2026.103336_bib75","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/eurjhf\/hfq152","article-title":"Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses","volume":"13","author":"Jabbour","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.arr.2026.103336_bib76","doi-asserted-by":"crossref","first-page":"145937","DOI":"10.1371\/journal.pone.0145937","article-title":"Analysis of tyrosine kinase inhibitor-mediated decline in contractile force in rat engineered heart tissue","volume":"11","author":"Jacob","year":"2016","journal-title":"PLoS. One"},{"key":"10.1016\/j.arr.2026.103336_bib77","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/metabo7030031","article-title":"Non-Targeted Metabolomics Analysis of the Effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Muscle, Liver and Serum Metabolism In Vivo","volume":"7","author":"Jensen","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.arr.2026.103336_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113280","article-title":"ATF4 protects against sorafenib-induced cardiotoxicity by suppressing ferroptosis","volume":"153","author":"Jiang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2026.103336_bib79","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.3748\/wjg.v29.i24.3748","article-title":"Vascular endothelial growth factor protein and gene delivery by novel nanomaterials for promoting liver regeneration after partial hepatectomy","volume":"29","author":"Jin","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.arr.2026.103336_bib80","doi-asserted-by":"crossref","first-page":"20160109","DOI":"10.1098\/rsfs.2016.0109","article-title":"Mitochondria-targeted metformins: anti-tumour and redox signalling mechanisms","volume":"7","author":"Kalyanaraman","year":"2017","journal-title":"Interface Focus."},{"key":"10.1016\/j.arr.2026.103336_bib81","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1016\/S1470-2045(18)30125-6","article-title":"Elderly patients with metastatic renal cell carcinoma: position paper from the International Society of Geriatric Oncology","volume":"19","author":"Kanesvaran","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib82","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/10641963.2017.1403623","article-title":"Pazopanib for renal cell carcinoma leads to elevated mean arterial pressures in a murine model","volume":"40","author":"Kempton","year":"2018","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.arr.2026.103336_bib83","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/CAD.0000000000001560","article-title":"Acute heart failure following pazopanib treatment: a literature review featuring two case reports","volume":"35","author":"Kertmen","year":"2024","journal-title":"Anticancer. Drugs"},{"key":"10.1016\/j.arr.2026.103336_bib84","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tem.2014.11.001","article-title":"Is AMPK the savior of the failing heart?","volume":"26","author":"Kim","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.arr.2026.103336_bib85","first-page":"135165","article-title":"Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter Study","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS. One"},{"key":"10.1016\/j.arr.2026.103336_bib86","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/igc.0000000000000602","article-title":"Pazopanib maintenance therapy in east asian women with advanced epithelial ovarian cancer: results from AGO-OVAR16 and an east asian study","volume":"28","author":"Kim","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.arr.2026.103336_bib87","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1161\/CIRCULATIONAHA.118.036099","article-title":"Endothelial cells regulate physiological cardiomyocyte growth via VEGFR2-mediated paracrine signaling","volume":"139","author":"Kivel\u00e4","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.arr.2026.103336_bib88","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12012-014-9266-y","article-title":"Mitogen-activated protein kinases pathways mediate the sunitinib-induced hypertrophy in rat cardiomyocyte H9c2 cells","volume":"15","author":"Korashy","year":"2015","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.arr.2026.103336_bib89","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/FJC.0000000000001256","article-title":"Metformin protects against sunitinib-induced cardiotoxicity: investigating the role of AMPK","volume":"79","author":"Kuburas","year":"2022","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib90","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2026.103336_bib91","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","article-title":"Cellular and molecular mechanisms of metformin action","volume":"42","author":"LaMoia","year":"2021","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.arr.2026.103336_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71816-y","article-title":"Three-dimensional alignment of microvasculature and cardiomyocytes in the developing ventricle","volume":"10","author":"Lapierre-Landry","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2026.103336_bib93","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41575-025-01099-z","article-title":"Liver, ageing and disease","volume":"22","author":"Le Couteur","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.arr.2026.103336_bib94","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-025-02249-0","article-title":"Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives","volume":"10","author":"Lee","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.arr.2026.103336_bib95","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12967-016-0847-3","article-title":"Dual effects of VEGF-B on activating cardiomyocytes and cardiac stem cells to protect the heart against short- and long-term ischemia-reperfusion injury","volume":"14","author":"Li","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.arr.2026.103336_bib96","article-title":"ATF3 promotes ferroptosis in sorafenib-induced cardiotoxicity by suppressing Slc7a11 expression","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib97","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00204-019-02448-z","article-title":"Upregulation of phosphoinositide 3-kinase prevents sunitinib-induced cardiotoxicity in vitro and in vivo","volume":"93","author":"Li","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.arr.2026.103336_bib98","doi-asserted-by":"crossref","first-page":"230","DOI":"10.11622\/smedj.2018051","article-title":"Traditional Chinese medicine: herb-drug interactions with aspirin","volume":"59","author":"Lim","year":"2018","journal-title":"Singap. Med. J."},{"key":"10.1016\/j.arr.2026.103336_bib99","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1007\/s00262-023-03520-5","article-title":"PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies","volume":"72","author":"Lin","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.arr.2026.103336_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.107017","article-title":"Sorafenib induces cardiotoxicity through RBM20-mediated alternative splicing of sarcomeric and mitochondrial genes","volume":"198","author":"Liu","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.arr.2026.103336_bib101","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/ars.2015.6615","article-title":"Nuclear factor E2-related factor-2 negatively regulates NLRP3 inflammasome activity by inhibiting reactive oxygen species-induced NLRP3 priming","volume":"26","author":"Liu","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.arr.2026.103336_bib102","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL Clinical Practice Guidelines: Drug-induced liver injury","volume":"70","author":"Liver","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.arr.2026.103336_bib103","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jhep.2004.03.016","article-title":"Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis","volume":"41","author":"Lluch","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.arr.2026.103336_bib104","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: An expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.arr.2026.103336_bib105","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1080\/15548627.2021.1886829","article-title":"AMPK protects against alcohol-induced liver injury through UQCRC2 to up-regulate mitophagy","volume":"17","author":"Lu","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.arr.2026.103336_bib106","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the european hematology association (EHA), the european society for therapeutic radiology and oncology (ESTRO) and the international cardio-oncology society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.arr.2026.103336_bib107","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/bcpt.13318","article-title":"Cardiotoxicity of sorafenib is mediated through elevation of ROS level and CaMKII activity and dysregulation of calcium homoeostasis","volume":"126","author":"Ma","year":"2020","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.arr.2026.103336_bib108","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s12020-022-03202-9","article-title":"Sorafenib decreases glycemia by impairing hepatic glucose metabolism","volume":"78","author":"Ma","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.arr.2026.103336_bib109","first-page":"5176","article-title":"Sorafenib-induced acute on chronic liver failure in a patient with hepatocellular carcinoma after microwave ablation","volume":"11","author":"Malik","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.arr.2026.103336_bib110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.physiol.65.092101.142249","article-title":"Stress-activated cytokines and the heart: from adaptation to maladaptation","volume":"65","author":"Mann","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.arr.2026.103336_bib111","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.6061\/clinics\/2021\/e2498","article-title":"Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma","volume":"76","author":"Marta","year":"2021","journal-title":"Clin. (Sao Paulo)"},{"issue":"1","key":"10.1016\/j.arr.2026.103336_bib112","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cam4.5130","article-title":"Clinical use of lenvatinib in patients with previous renal and\/or hepatic impairment and radioiodine-refractory differentiated thyroid cancer","volume":"11","author":"Mart\u00ednez-Trufero","year":"2022","journal-title":"Cancer Med."},{"key":"10.1016\/j.arr.2026.103336_bib113","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1071-9164(96)80076-5","article-title":"Newer aspects of pathogenesis of heart failure: hepatitis C virus infection in myocarditis and cardiomyopathy","volume":"2","author":"Matsumori","year":"1996","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.arr.2026.103336_bib114","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/03602532.2020.1832112","article-title":"The development and hepatotoxicity of acetaminophen: reviewing over a century of progress","volume":"52","author":"McGill","year":"2020","journal-title":"Drug. Metab. Rev."},{"key":"10.1016\/j.arr.2026.103336_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102333","article-title":"Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A review","volume":"103","author":"McGregor","year":"2022","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.arr.2026.103336_bib116","unstructured":"Medicine(US), N.L.o., 2023. Metformin hydrochloride(Dailymed)\uff1adrug label information. National Library of Medicine (US)."},{"key":"10.1016\/j.arr.2026.103336_bib117","unstructured":"Medicine(US), N.L.o., 2024. CYCLOSPORINE capsule, liquid filled (DailyMed): Drug label information. National Library of Medicine (US)."},{"key":"10.1016\/j.arr.2026.103336_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115149","article-title":"Safety analysis of co-administering tacrolimus and omeprazole in renal transplant recipients - A review","volume":"166","author":"Miedziaszczyk","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2026.103336_bib119","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jat.3551","article-title":"Mechanisms of toxicity associated with six tyrosine kinase inhibitors in human hepatocyte cell lines","volume":"38","author":"Mingard","year":"2018","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.arr.2026.103336_bib120","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","article-title":"Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study","volume":"398","author":"Mohile","year":"2021","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.arr.2026.103336_bib121","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S1470-2045(15)00290-9","article-title":"Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial","volume":"16","author":"Motzer","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib122","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2026.103336_bib123","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.arr.2026.103336_bib124","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12885-015-1683-1","article-title":"Do Multidisciplinary Team (MDT) processes influence survival in patients with colorectal cancer? A population-based experience","volume":"15","author":"Munro","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.arr.2026.103336_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjon.2024.100624","article-title":"Frequency of ischemic cardiac events in patients receiving long-term multikinase inhibitor: A report of three cases","volume":"12","author":"Muraoka","year":"2025","journal-title":"Asia Pac. J. Oncol. Nurs."},{"key":"10.1016\/j.arr.2026.103336_bib126","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1158\/1078-0432.CCR-16-2869","article-title":"Prospective evaluation of sunitinib-induced cardiotoxicity in patients with metastatic renal cell carcinoma","volume":"23","author":"Narayan","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.arr.2026.103336_bib127","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/HYPERTENSIONAHA.117.10490","article-title":"VEGFR (vascular endothelial growth factor receptor) inhibition induces cardiovascular damage via redox-sensitive processes","volume":"71","author":"Neves","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.arr.2026.103336_bib128","first-page":"169964","article-title":"A novel positron emission tomography (PET) approach to monitor cardiac metabolic pathway remodeling in response to sunitinib malate","volume":"12","author":"O'Farrell","year":"2017","journal-title":"PLoS. One"},{"key":"10.1016\/j.arr.2026.103336_bib129","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pharep.2015.09.007","article-title":"Hesperidin alleviates cisplatin-induced hepatotoxicity in rats without inhibiting its antitumor activity","volume":"68","author":"Omar","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.arr.2026.103336_bib130","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/MOT.0000000000000801","article-title":"Immune benefit of combined heart and liver transplantation","volume":"25","author":"Ortega-Legaspi","year":"2020","journal-title":"Curr. Opin. Organ. Transplant."},{"key":"10.1016\/j.arr.2026.103336_bib131","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jacc.2015.10.081","article-title":"Cyclosporine A in Reperfused Myocardial Infarction: The Multicenter, Controlled, Open-Label CYCLE Trial","volume":"67","author":"Ottani","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.arr.2026.103336_bib132","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tox.2018.07.009","article-title":"Sunitinib induces hepatocyte mitochondrial damage and apoptosis in mice","volume":"409","author":"Paech","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.arr.2026.103336_bib133","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tox.2018.01.005","article-title":"Mechanisms of mitochondrial toxicity of the kinase inhibitors ponatinib, regorafenib and sorafenib in human hepatic HepG2 cells","volume":"395","author":"Paech","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.arr.2026.103336_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2023.151545","article-title":"The role of nurses in the management of adverse events in patients receiving first-line axitinib plus immuno-oncology agents for advanced renal cell carcinoma","volume":"40","author":"Parreira","year":"2024","journal-title":"Semin. Oncol. Nurs."},{"key":"10.1016\/j.arr.2026.103336_bib135","article-title":"Cardiovascular risk factors management in older adults: a clinical consensus statement from the European Association of Preventive Cardiology of the ESC and the ESC Council for Cardiology Practice","volume":"175","author":"Pedretti","year":"2025","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.arr.2026.103336_bib136","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1111\/jgh.15523","article-title":"Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population","volume":"36","author":"Pennisi","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.arr.2026.103336_bib137","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jcmg.2017.11.024","article-title":"Stone liver, heart in danger: could the liver stiffness assessment improve the management of patients with heart failure","volume":"12","author":"Pernot","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.arr.2026.103336_bib138","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.clgc.2019.01.018","article-title":"Real-world effectiveness and safety of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma","volume":"17","author":"Procopio","year":"2019","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.arr.2026.103336_bib139","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/ijc.27979","article-title":"Risk of venous thromboembolic events associated with VEGFR-TKIs: a systematic review and meta-analysis","volume":"132","author":"Qi","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.arr.2026.103336_bib140","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.cmet.2023.03.013","article-title":"DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates","volume":"35","author":"Qu","year":"2023","journal-title":"Cell. Metab."},{"key":"10.1016\/j.arr.2026.103336_bib141","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.680758","article-title":"Polydatin reduces cardiotoxicity and enhances the anticancer effects of sunitinib by decreasing pro-oxidative stress, pro-inflammatory cytokines, and NLRP3 inflammasome expression","volume":"11","author":"Quagliariello","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.664181","article-title":"Sodium-glucose cotransporter-2 inhibitor empagliflozin ameliorates sunitinib-induced cardiac dysfunction via regulation of AMPK-mTOR Signaling pathway-mediated autophagy","volume":"12","author":"Ren","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib143","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1200\/JCO.2010.34.4309","article-title":"Incidence and risk of congestive heart failure in patients with renal and nonrenal cell carcinoma treated with sunitinib","volume":"29","author":"Richards","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib144","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11864-020-00812-1","article-title":"Metabolic aspects of anthracycline cardiotoxicity","volume":"22","author":"Russo","year":"2021","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib145","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1253\/circj.CJ-14-0182","article-title":"Modeling inherited cardiac disorders","volume":"78","author":"Sallam","year":"2014","journal-title":"Circ. J."},{"key":"10.1016\/j.arr.2026.103336_bib146","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejphar.2017.08.011","article-title":"Attenuation of Sunitinib-induced cardiotoxicity through the A3 adenosine receptor activation","volume":"814","author":"Sandhu","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib147","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ctrv.2017.07.006","article-title":"Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies","volume":"59","author":"Santoni","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.arr.2026.103336_bib148","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00432-016-2161-0","article-title":"Phase I trial of dovitinib (TKI258) in recurrent glioblastoma","volume":"142","author":"Sch\u00e4fer","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib149","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/EJE-13-0015","article-title":"Toxic cardiomyopathy leading to fatal acute cardiac failure related to vandetanib: a case report with histopathological analysis","volume":"168","author":"Scheffel","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.arr.2026.103336_bib150","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1200\/JCO.2007.15.6331","article-title":"Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma","volume":"26","author":"Schmidinger","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189079","article-title":"VEGF signaling: Role in angiogenesis and beyond","volume":"1879","author":"Shaw","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.arr.2026.103336_bib152","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.21037\/atm-22-5438","article-title":"Anlotinib suppresses lung adenocarcinoma growth via inhibiting FASN-mediated lipid metabolism","volume":"10","author":"Shen","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.arr.2026.103336_bib153","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/cvr\/cvz006","article-title":"Ponatinib-induced cardiotoxicity: delineating the signalling mechanisms and potential rescue strategies","volume":"115","author":"Singh","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.arr.2026.103336_bib154","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1634\/theoncologist.2018-0891","article-title":"Cardiotoxicity monitoring in patients treated with tyrosine kinase inhibitors","volume":"24","author":"Skubitz","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.arr.2026.103336_bib155","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10545-015-9838-4","article-title":"Vascular endothelial growth factors: multitasking functionality in metabolism, health and disease","volume":"38","author":"Smith","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.arr.2026.103336_bib156","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.7150\/thno.19551","article-title":"Cardiac metabolic deregulation induced by the tyrosine kinase receptor inhibitor sunitinib is rescued by endothelin receptor antagonism","volume":"7","author":"Sourdon","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.arr.2026.103336_bib157","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/genes15020177","article-title":"Cardiac and nephrological complications related to the use of antiangiogenic and anti-programmed cell death Protein 1 receptor\/programmed cell death protein 1 ligand therapy","volume":"15","author":"Stachyra-Strawa","year":"2024","journal-title":"Genes. (Basel)"},{"key":"10.1016\/j.arr.2026.103336_bib158","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1200\/JCO.2009.23.9764","article-title":"Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial","volume":"28","author":"Sternberg","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib159","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1080\/13880209.2021.1998140","article-title":"Gambogic amide inhibits angiogenesis by suppressing VEGF\/VEGFR2 in endothelial cells in a TrkA-independent manner","volume":"59","author":"Sui","year":"2021","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.arr.2026.103336_bib160","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/CIRCULATIONAHA.115.020894","article-title":"Gastrointestinal and liver issues in heart failure","volume":"133","author":"Sundaram","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.arr.2026.103336_bib161","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16146","article-title":"Epidemiology and Risk Determinants of Drug-Induced Liver Injury: Current Knowledge and Future Research Needs","volume":"45","author":"Suzuki","year":"2025","journal-title":"Liver Int."},{"key":"10.1016\/j.arr.2026.103336_bib162","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/hepr.13427","article-title":"Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching","volume":"50","author":"Tada","year":"2020","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.arr.2026.103336_bib163","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jhep.2023.02.012","article-title":"Issues in multi-organ transplantation of the liver with kidney or heart in polycystic liver-kidney disease or congenital heart disease: Current practices and immunological aspects","volume":"78","author":"Taner","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.arr.2026.103336_bib164","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1002142","article-title":"Sunitinib induced hepatotoxicity in L02 cells via ROS-MAPKs signaling pathway","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib165","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1177\/1078155220909422","article-title":"Left ventricular dysfunction associated with axitinib and nivolumab experience in an advanced renal cell carcinoma","volume":"26","author":"Tanriverdi","year":"2020","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.arr.2026.103336_bib166","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.amjmed.2015.07.033","article-title":"The incidence and outcomes of ischemic hepatitis: a systematic review with meta-analysis","volume":"128","author":"Tapper","year":"2015","journal-title":"Am. J. Med."},{"key":"10.1016\/j.arr.2026.103336_bib167","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/cvr\/cvab115","article-title":"Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable production","volume":"118","author":"Thomas","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.arr.2026.103336_bib168","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/2047487318755193","article-title":"Cardiovascular diseases in patients receiving small molecules with anti-vascular endothelial growth factor activity: A meta-analysis of approximately 29,000 cancer patients","volume":"25","author":"Totzeck","year":"2018","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.arr.2026.103336_bib169","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"379","author":"van der Graaf","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2026.103336_bib170","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3390\/cancers15061766","article-title":"Hepatotoxicity of small molecule protein kinase inhibitors for cancer","volume":"15","author":"Vigan\u00f2","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arr.2026.103336_bib171","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.2337\/db12-1619","article-title":"Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function","volume":"62","author":"Villalta","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.arr.2026.103336_bib172","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1007\/s12325-017-0628-2","article-title":"Clinical and Economic Outcomes in Elderly Advanced Renal Cell Carcinoma Patients Starting Pazopanib or Sunitinib Treatment: A Retrospective Medicare Claims Analysis","volume":"34","author":"Vogelzang","year":"2017","journal-title":"Adv. Ther."},{"key":"10.1016\/j.arr.2026.103336_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104298","article-title":"Higher risk of hepatotoxicity associated with cabozantinib in cancer patients","volume":"196","author":"Wang","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.arr.2026.103336_bib174","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cels.2019.03.009","article-title":"Adaptation of human iPSC-derived cardiomyocytes to tyrosine kinase inhibitors reduces acute cardiotoxicity via metabolic reprogramming","volume":"8","author":"Wang","year":"2019","journal-title":"Cell. Syst."},{"key":"10.1016\/j.arr.2026.103336_bib175","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/00498254.2018.1489167","article-title":"A metabolomic perspective of pazopanib-induced acute hepatotoxicity in mice","volume":"49","author":"Wang","year":"2019","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.arr.2026.103336_bib176","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2011.35.5040","article-title":"Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial","volume":"30","author":"Wells","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.arr.2026.103336_bib177","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tox.2014.11.002","article-title":"Regorafenib impairs mitochondrial functions, activates AMP-activated protein kinase, induces autophagy, and causes rat hepatocyte necrosis","volume":"327","author":"Weng","year":"2015","journal-title":"Toxicology"},{"key":"10.1016\/j.arr.2026.103336_bib178","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jchf.2018.10.007","article-title":"Heart failure and liver disease","volume":"7","author":"Xanthopoulos","year":"2019","journal-title":"cardiohepatic Interact. JACC Heart Fail."},{"key":"10.1016\/j.arr.2026.103336_bib179","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.apsb.2021.12.023","article-title":"Gentiopicroside targets PAQR3 to activate the PI3K\/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism","volume":"12","author":"Xiao","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.arr.2026.103336_bib180","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1080\/15548627.2021.1965712","article-title":"Autophagic degradation of CCN2 (cellular communication network factor 2) causes cardiotoxicity of sunitinib","volume":"18","author":"Xu","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.arr.2026.103336_bib181","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/toxsci\/kfae127","article-title":"Schisandrin C prevents regorafenib-induced cardiotoxicity by recovering EPHA2 expression in cardiomyocytes","volume":"202","author":"Xu","year":"2024","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.arr.2026.103336_bib182","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1038\/s41467-023-38430-8","article-title":"Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK\/MDM2\/p53 axis","volume":"14","author":"Yan","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103336_bib183","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cbi.2016.08.006","article-title":"Progress on the cardiotoxicity of sunitinib: Prognostic significance, mechanism and protective therapies","volume":"257","author":"Yang","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.arr.2026.103336_bib184","doi-asserted-by":"crossref","first-page":"44121","DOI":"10.18632\/oncotarget.17310","article-title":"A phase II trial of regorafenib in patients with metastatic and\/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17","volume":"8","author":"Yeh","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.arr.2026.103336_bib185","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2147\/CMAR.S191499","article-title":"Treatment-related adverse effects with TKIs in patients with advanced or radioiodine refractory differentiated thyroid carcinoma: a systematic review and meta-analysis","volume":"11","author":"Yu","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.arr.2026.103336_bib186","doi-asserted-by":"crossref","first-page":"271631","DOI":"10.1371\/journal.pone.0271631","article-title":"Hesperetin mitigates sorafenib-induced cardiotoxicity in mice through inhibition of the TLR4\/NLRP3 signaling pathway","volume":"17","author":"Zaafar","year":"2022","journal-title":"PLoS. One"},{"key":"10.1016\/j.arr.2026.103336_bib187","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/bcp.15576","article-title":"Incidence of heart failure following exposure to a protein kinase inhibitor, a French population-based study","volume":"89","author":"Zelmat","year":"2023","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107278","article-title":"Recent development of VEGFR small molecule inhibitors as anticancer agents: A patent review (2021-2023)","volume":"146","author":"Zeng","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.arr.2026.103336_bib189","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1074\/jbc.M116.763532","article-title":"Specific inhibition of acyl-CoA oxidase-1 by an acetylenic Acid improves hepatic lipid and reactive oxygen species (ROS) metabolism in rats fed a high fat diet","volume":"292","author":"Zeng","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103336_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113475","article-title":"Chinese medicine GeGen-DanShen extract protects from myocardial ischemic injury through promoting angiogenesis via up-regulation of VEGF\/VEGFR2 signaling pathway","volume":"267","author":"Zhai","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib191","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-025-01145-0","article-title":"Thirty years of NRF2: advances and therapeutic challenges","volume":"24","author":"Zhang","year":"2025","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.arr.2026.103336_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112133","article-title":"MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis","volume":"143","author":"Zhang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2026.103336_bib193","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1007\/s00204-016-1918-1","article-title":"Effects of 31 FDA approved small-molecule kinase inhibitors on isolated rat liver mitochondria","volume":"91","author":"Zhang","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.arr.2026.103336_bib194","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9502895","article-title":"Glycine protects H9C2 cardiomyocytes from high glucose- and hypoxia\/reoxygenation-induced injury via inhibiting PKC\u03b22 activation and improving mitochondrial quality","volume":"2018","author":"Zhang","year":"2018","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.arr.2026.103336_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116169","article-title":"Sorafenib reduces the production of epoxyeicosatrienoic acids and leads to cardiac injury by inhibiting CYP2J in rats","volume":"223","author":"Zhang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib196","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib197","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.7150\/thno.99926","article-title":"Gut microbiota depletion and FXR inhibition exacerbates zonal hepatotoxicity of sunitinib","volume":"14","author":"Zhao","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.arr.2026.103336_bib198","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2018.04.006","article-title":"CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis","volume":"69","author":"Zhao","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.arr.2026.103336_bib199","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1111\/bph.14664","article-title":"Impaired clearance of sunitinib leads to metabolic disorders and hepatotoxicity","volume":"176","author":"Zhao","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1515\/dmdi-2011-0038","article-title":"Herb-drug interactions with Danshen (Salvia miltiorrhiza): a review on the role of cytochrome P450 enzymes","volume":"27","author":"Zhou","year":"2012","journal-title":"Drug. Metabol. Drug. Interact."},{"key":"10.1016\/j.arr.2026.103336_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.113045","article-title":"Metabolic pro\ufb01ling of tyrosine kinase inhibitor nintedanib using metabolomics","volume":"180","author":"Zhou","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.arr.2026.103336_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175235","article-title":"Amorphous selenium nanodots alleviate non-alcoholic fatty liver disease via activating VEGF receptor 1 to further inhibit phosphorylation of JNK\/p38 MAPK pathways","volume":"932","author":"Zhu","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.arr.2026.103336_bib203","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1111\/jcmm.15180","article-title":"Cardiac metabolism as a driver and therapeutic target of myocardial infarction","volume":"24","author":"Zuurbier","year":"2020","journal-title":"J. Cell. Mol. Med."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726003284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726003284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:38:43Z","timestamp":1791646723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163726003284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":203,"alternative-id":["S1568163726003284"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103336","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms and therapeutic strategies for VEGFR inhibitor-induced cardiotoxicity and hepatotoxicity in cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103336"}}